Location History:
- Vallensb.ae butted.k, DK (1999)
- Vallensbæk, DK (2001)
Company Filing History:
Years Active: 1999-2001
Title: **Ann Louring Roldan: Innovator in Urokinase-type Plasminogen Activator Research**
Introduction
Ann Louring Roldan is a remarkable inventor based in Vallensbæk, Denmark, known for her impactful contributions to the field of medical research, particularly concerning urokinase-type plasminogen activator receptors. With a total of two patents to her name, her work is not only innovative but also crucial for advancements in therapies for various diseases.
Latest Patents
Roldan's latest patents focus on the inhibition of plasminogen activation. Her first patent describes the mechanism by which the binding of urokinase-type plasminogen activator to its receptor is prevented in mammals, thus impeding the conversion of plasminogen into plasmin. In addition, she provides DNA fragments that encode for soluble, active fragments of these receptors, facilitating further research and application in medical therapies. Her second patent elaborates on vectors and methods for the recombinant production of uPA-binding fragments, similarly aimed at inhibiting plasminogen activation through receptor binding prevention.
Career Highlights
Roldan is affiliated with the Cancer Research Fund of 1989, where she has made significant strides in her research. Her work not only contributes to the scientific community but holds promise for clinical applications that can improve patient outcomes in cancer treatment and other related health conditions.
Collaborations
Throughout her career, Roldan has collaborated with esteemed colleagues such as Francesco Blasi and Maria Vittoria Cubellis. These partnerships enhance her research and contribute to the collective knowledge in the field of cancer research and plasminogen activation.
Conclusion
Ann Louring Roldan's innovations represent a vital step forward in understanding and treating diseases influenced by urokinase-type plasminogen activator receptors. Through her patents, she demonstrates the potential of scientific research to lead to significant medical advancements. Her collaboration with notable researchers further solidifies her position as an influential figure in the realm of medical innovations.